Shareholding disclosure
The Swiss Helvetia Fund Inc
Declared position
4.92%
Threshold
Crossed upwards
Timeline
Published
20.03.2008
Transaction
01.12.2007
Transfer date
01.12.2007
Voting rights breakdown
Voting rights acquired4.92%
Voting rights sold0%
Below threshold0%
Notice details
CategoryGroup of shareholders
ExchangeXSWX
Notification ID
T5947D5704
Beneficial owner
The Swiss Helvetia Fund Inc
Declared address
The Swiss Helvetia Fund Inc., New York
Based on article 16 SESTO-FBC (Börsenverordnung-EBK) The Swiss Helvetia Fund, Inc., 1270 Avenue of the Americas, Suite 400, New York, NY 10020, USA, has informed Addex Pharmaceuticals Ltd., Geneva, on March 13, 2008, of exceeding the threshold of 3% in the shareholding of Addex Pharmaceuticals Ltd., holding a total of 288,360 registered shares, corresponding to 4.92% of the voting rights.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open